Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab
Open Access
- 5 September 2005
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 36 (9) , 797-802
- https://doi.org/10.1038/sj.bmt.1705121
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 yearsBlood, 2003
- HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignanciesBlood, 2003
- Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancyTransplantation and Cellular Therapy, 2003
- Anti-CD45–mediated cytoreduction to facilitate allogeneic stem cell transplantationBlood, 2003
- Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approachesTransplantation and Cellular Therapy, 2001
- Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimenBone Marrow Transplantation, 2001
- Nonmyeloablative Hematopoietic Cell TransplantationAnnals of the New York Academy of Sciences, 2001
- CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cellsBone Marrow Transplantation, 2000
- Mini-allografts: ongoing trials in humansBone Marrow Transplantation, 2000
- THERAPEUTIC POTENTIAL OF MONOCLONAL ANTIBODIES TO THE LEUKOCYTE-COMMON ANTIGENTransplantation, 1985